# Zivo Bioscience, Inc.: filings

ZIVO · OTC · CIK 1101026 · [Healthcare](/sectors/healthcare.md) · fiscal year ends Dec 31

Pages: [Overview](/companies/zivo.md) · [Financials](/companies/zivo/financials.md) · [Filings](/companies/zivo/filings.md) · [Insiders](/companies/zivo/insiders.md)

## Reports and events: 264 filings

Newest first, by EDGAR acceptance time (Eastern). Filter with ?form= one of: `periodic`, `8-K`, `10-K`, `10-Q`, `4`, `proxy`, `13dg`, `all`, or any form this company filed (4 182, 8-K 123, 10-Q 51, D/A 31, SC 13D/A 22, D 20, 3 19, DEF 14A 18, 10-K 17, CORRESP 11, UPLOAD 11, SC 13D 10, SC 13G/A 10, 4/A 8, PRE 14A 8, 10-Q/A 6, DEFR14A 6, 8-K/A 5, DEFA14A 5, NT 10-K 5, NT 10-Q 5, S-1/A 5, EFFECT 4, SC 13G 4, ARS 3, S-1 3, 10-K/A 2, 3/A 2, 5 2, PRER14A 2, RW 2, S-3 2, SCHEDULE 13D/A 2, 15-12G 1, 25-NSE 1, 424B3 1, 424B4 1, 424B5 1, 8-A12B 1, CERT 1, NT 10-Q/A 1, POS AM 1, S-1MEF 1, S-8 1, S-8 POS 1).

| Filed | Accepted | Form | What it is | Accession |
| --- | --- | --- | --- | --- |
| 2026-03-30 | 08:01 ET | [8-K](/filings/0001654954-26-002928.md) | 5.02 Departure or appointment of officers or directors; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001654954-26-002928 |
| 2026-02-27 | 20:20 ET | [SCHEDULE 13D/A](/filings/0001213900-26-021894.md) | Ownership report, active investor, amended | 0001213900-26-021894 |
| 2025-12-23 | 16:06 ET | [8-K](/filings/0001654954-25-014296.md) | 5.02 Departure or appointment of officers or directors; 9.01 Financial statements and exhibits | 0001654954-25-014296 |
| 2025-11-14 | 16:39 ET | [10-Q](/filings/0001654954-25-013095.md) | Quarterly report, period 2025-09-30 | 0001654954-25-013095 |
| 2025-09-10 | 09:49 ET | [8-K](/filings/0001654954-25-010579.md) | 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001654954-25-010579 |
| 2025-08-18 | 16:12 ET | [8-K](/filings/0001654954-25-009772.md) | 5.02 Departure or appointment of officers or directors | 0001654954-25-009772 |
| 2025-08-14 | 16:21 ET | [10-Q](/filings/0001654954-25-009650.md) | Quarterly report, period 2025-06-30 | 0001654954-25-009650 |
| 2025-07-14 | 16:59 ET | [8-K](/filings/0001654954-25-008035.md) | 1.01 Entry into a material agreement; 2.03 New direct financial obligation; 9.01 Financial statements and exhibits | 0001654954-25-008035 |
| 2025-06-11 | 16:10 ET | [8-K](/filings/0001654954-25-006837.md) | 5.07 Shareholder vote results | 0001654954-25-006837 |
| 2025-05-15 | 16:10 ET | [10-Q](/filings/0001654954-25-005748.md) | Quarterly report, period 2025-03-31 | 0001654954-25-005748 |
| 2025-04-25 | 16:36 ET | [DEF 14A](/filings/0001654954-25-004654.md) | Proxy statement, period 2025-04-25 | 0001654954-25-004654 |
| 2025-03-18 | 16:10 ET | [10-K](/filings/0001654954-25-002948.md) | Annual report, period 2024-12-31 | 0001654954-25-002948 |
| 2025-01-27 | 17:21 ET | [8-K](/filings/0001654954-25-000805.md) | 3.02 Unregistered sale of equity | 0001654954-25-000805 |
| 2025-01-15 | 17:14 ET | [8-K](/filings/0001654954-25-000453.md) | 1.01 Entry into a material agreement; 9.01 Financial statements and exhibits | 0001654954-25-000453 |
| 2025-01-07 | 16:05 ET | [8-K](/filings/0001654954-25-000173.md) | 8.01 Other events | 0001654954-25-000173 |
| 2024-11-15 | 06:30 ET | [8-K](/filings/0001654954-24-014503.md) | 1.01 Entry into a material agreement; 2.03 New direct financial obligation; 9.01 Financial statements and exhibits | 0001654954-24-014503 |
| 2024-11-14 | 16:19 ET | [10-Q](/filings/0001654954-24-014463.md) | Quarterly report, period 2024-09-30 | 0001654954-24-014463 |
| 2024-10-18 | 17:26 ET | [8-K](/filings/0001654954-24-013107.md) | 3.02 Unregistered sale of equity | 0001654954-24-013107 |
| 2024-10-01 | 14:57 ET | [SC 13D/A](/filings/0001618035-24-000005.md) | Ownership report, active investor, amended | 0001618035-24-000005 |
| 2024-08-14 | 16:10 ET | [10-Q](/filings/0001654954-24-010644.md) | Quarterly report, period 2024-06-30 | 0001654954-24-010644 |
| 2024-07-17 | 16:26 ET | [8-K](/filings/0001654954-24-009069.md) | 5.02 Departure or appointment of officers or directors | 0001654954-24-009069 |
| 2024-06-13 | 16:47 ET | [8-K](/filings/0001654954-24-007730.md) | 5.07 Shareholder vote results | 0001654954-24-007730 |
| 2024-06-12 | 20:49 ET | [SC 13D](/filings/0001654954-24-007677.md) | Ownership report, active investor | 0001654954-24-007677 |
| 2024-06-12 | 20:44 ET | [SC 13D](/filings/0001654954-24-007676.md) | Ownership report, active investor | 0001654954-24-007676 |
| 2024-06-12 | 20:36 ET | [SC 13D](/filings/0001654954-24-007675.md) | Ownership report, active investor | 0001654954-24-007675 |
| 2024-06-07 | 21:22 ET | [SC 13D/A](/filings/0001654954-24-007537.md) | Ownership report, active investor, amended | 0001654954-24-007537 |
| 2024-06-07 | 06:02 ET | [8-K/A](/filings/0001654954-24-007479.md) | 1.01 Entry into a material agreement | 0001654954-24-007479 |
| 2024-06-06 | 16:54 ET | [8-K](/filings/0001654954-24-007455.md) | 1.01 Entry into a material agreement; 3.02 Unregistered sale of equity; 5.02 Departure or appointment of officers or directors; 9.01 Financial statements and exhibits | 0001654954-24-007455 |
| 2024-05-13 | 16:38 ET | [10-Q](/filings/0001654954-24-006082.md) | Quarterly report, period 2024-03-31 | 0001654954-24-006082 |
| 2024-04-26 | 08:00 ET | [DEF 14A](/filings/0001654954-24-005060.md) | Proxy statement, period 2024-06-11 | 0001654954-24-005060 |
| 2024-04-09 | 11:49 ET | [SC 13D/A](/filings/0001174947-24-000523.md) | Ownership report, active investor, amended | 0001174947-24-000523 |
| 2024-03-15 | 16:43 ET | [10-K](/filings/0001654954-24-003228.md) | Annual report, period 2023-12-31 | 0001654954-24-003228 |
| 2024-03-14 | 09:16 ET | [SCHEDULE 13D/A](/filings/0001618035-24-000004.md) | Ownership report, active investor, amended | 0001618035-24-000004 |
| 2024-02-15 | 16:45 ET | [8-K](/filings/0001654954-24-001856.md) | 3.01 Delisting notice | 0001654954-24-001856 |
| 2024-01-22 | 17:15 ET | [SC 13D](/filings/0001654954-24-000795.md) | Ownership report, active investor | 0001654954-24-000795 |
| 2024-01-17 | 16:11 ET | [8-K](/filings/0001654954-24-000694.md) | 3.02 Unregistered sale of equity | 0001654954-24-000694 |
| 2024-01-05 | 17:17 ET | [8-K](/filings/0001654954-24-000274.md) | 3.02 Unregistered sale of equity | 0001654954-24-000274 |
| 2024-01-03 | 17:23 ET | [8-K](/filings/0001654954-24-000154.md) | 3.02 Unregistered sale of equity | 0001654954-24-000154 |
| 2023-12-11 | 16:42 ET | [8-K](/filings/0001654954-23-015370.md) | 3.02 Unregistered sale of equity | 0001654954-23-015370 |
| 2023-11-27 | 09:29 ET | [8-K](/filings/0001654954-23-014775.md) | 3.01 Delisting notice | 0001654954-23-014775 |
| 2023-11-22 | 16:21 ET | [8-K](/filings/0001654954-23-014712.md) | 1.01 Entry into a material agreement; 2.03 New direct financial obligation; 9.01 Financial statements and exhibits | 0001654954-23-014712 |
| 2023-11-13 | 16:18 ET | [10-Q](/filings/0001654954-23-014165.md) | Quarterly report, period 2023-09-30 | 0001654954-23-014165 |
| 2023-11-03 | 10:18 ET | [S-1/A](/filings/0001654954-23-013753.md) | Registration statement, amended | 0001654954-23-013753 |
| 2023-11-01 | 18:20 ET | [S-1/A](/filings/0001654954-23-013618.md) | Registration statement, amended | 0001654954-23-013618 |
| 2023-10-30 | 13:20 ET | [SC 13D/A](/filings/0001174947-23-001251.md) | Ownership report, active investor, amended | 0001174947-23-001251 |
| 2023-10-26 | 08:56 ET | [8-K](/filings/0001654954-23-013408.md) | 3.03 Change to security holders’ rights; 5.03 Amendment to articles or bylaws; 9.01 Financial statements and exhibits | 0001654954-23-013408 |
| 2023-10-04 | 17:08 ET | [S-1](/filings/0001654954-23-012588.md) | Registration statement | 0001654954-23-012588 |
| 2023-08-14 | 16:17 ET | [10-Q](/filings/0001654954-23-010769.md) | Quarterly report, period 2023-06-30 | 0001654954-23-010769 |
| 2023-08-09 | 16:17 ET | [8-K](/filings/0001654954-23-010378.md) | 3.01 Delisting notice | 0001654954-23-010378 |
| 2023-07-06 | 16:24 ET | [8-K](/filings/0001654954-23-008880.md) | 1.01 Entry into a material agreement; 3.02 Unregistered sale of equity; 9.01 Financial statements and exhibits | 0001654954-23-008880 |

Page 1 of 6. [Older](/companies/zivo/filings.md?page=2)
Source: SEC EDGAR, the company’s filing index. Last ingested by Listed: Oct 24, 2026, 15:04 ET. No prices; not investment advice.